Bleeding risk ends aspirin-clopidogrel trial

10/10/2011 | TheHeart.org (Montreal) (free registration)

The National Institute of Neurological Disorders and Stroke has halted the study of an aspirin-clopidogrel combination in the Secondary Prevention of Small Subcortical Strokes trial. Mortality rates and bleeding risk were higher for that combination, and an analysis showed little chance of benefit.

View Full Article in:

TheHeart.org (Montreal) (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
CT
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC